GSE236502 paclitaxel 1 v 3 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE236502_paclitaxel_1_v_3_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE236502_paclitaxel_1_v_3_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE236502_paclitaxel_1_v_3_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE236502_paclitaxel_1_v_3_human_up.

Results found

Linked to

 

Label

Description

 

Gene

PAX8 antisense RNA 1

Gene

double homeobox A pseudogene 8

Gene

protein kinase Y-linked (pseudogene)

Gene

taxilin gamma Y-linked (pseudogene)

Gene

nicotinamide phosphoribosyltransferase pseudogene 1

Gene

ubiquitin specific peptidase 32 pseudogene 1

Gene

ITGB2 antisense RNA 1

Gene

CHD9 neighbor

Gene

ANAPC1 pseudogene 2

Gene

AFG3 like matrix AAA peptidase subunit 1, pseudogene

  • Gene

    PAX8 antisense RNA 1


  • Gene

    double homeobox A pseudogene 8


  • Gene

    protein kinase Y-linked (pseudogene)


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • Gene

    nicotinamide phosphoribosyltransferase pseudogene 1


  • Gene

    ubiquitin specific peptidase 32 pseudogene 1


  • Gene

    ITGB2 antisense RNA 1



  • Gene

    ANAPC1 pseudogene 2


  • Gene

    AFG3 like matrix AAA peptidase subunit 1, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.